BioNTech SE (BNTX)
BioNTech SE FCF to Net Income
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | 0.0% | 128.4% | 264.4% | 150.3% | 67.8% | 4.9% | 102.0% | 393.4% |
BioNTech SE (BNTX) FCF to Net Income comparison analysis
BNTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is BioNTech SE's FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is (312.1%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for BioNTech SE have been 208.0% over the past three years, and 192.7% over the past five years.
2) Is BioNTech SE's FCF to Net Income Good?
As of today, BioNTech SE's FCF to Net Income is (312.1%), which is lower than industry median of 83.9%. It indicates that BioNTech SE's FCF to Net Income is Bad.